Back

Impact of sarcopenia and dynapenia on the prognosis of patients at high risk of pulmonary hypertension

18 May 2025 (16:00 - 16:45)
Organised by: Logo
Congress Presentation Part of: Pulmonary circulation Pulmonary Hypertension HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Maria Jose Hernandez Hernandez

Mexico City (Mexico)

4 More presentations in this session

Presentation thumbnail
Impact of FlowTriever system on hemodynamics and safety in PE: results from a FlowTriever System Cohort
Doctor M. Caetano Coelho (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Risk assessment in patients with intermediate to high-risk pulmonary embolism: can the validated scores help predict the necessity of reperfusion therapy?
Doctor F. Rodrigues Santos (Viseu, PT)
Abstract Slides Video
Presentation thumbnail
Pulmonary arterial hypertension and connective tissue disease "multidisciplinar management, beyond a utopia"
Doctor G. Sorasio (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
Oxygen therapy in CTEPH patients: prevalence and associated factors
Mrs L. Brochado (Almada, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Pulmonary circulation

The Event

Event poster

Heart Failure 2025

18 May 2025 16:00 CET
You may be interested in
thumbnail
Congress Presentation
Impact of sarcopenia and dynapenia on the prognosis of right heart failure
thumbnail
Congress Presentation
Impact of sarcopenia and osteopenia on prognosis in elderly heart failure patients: a computed tomography-based comparative study
thumbnail
Congress Presentation
The association between sarcopenia and post-discharge outcomes in patients with heart failure: data from the SMILE HF registry

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources